Power Hour Pulse: Biotech Surge and AI Sparks — Watch these Stocks into the Close

September 9, 2025

DENVER, Colo., Sep 09, 2025 (247marketnews.com)- As markets push into the final hour of trading, all eyes are on a high-energy mix of biotech, AI, and consumer health stocks. Here are today’s standout plays going into the close.

Lixte Biotechnology (NASDAQ:LIXT) is making a powerful move late in the session, eyeing a breakout to new 52-week highs on bullish sentiment surrounding its lead compound LB-100, a PP2A inhibitor dubbed a “cancer power-up” for its ability to amplify the effects of both chemotherapy and immunotherapy. Now in clinical trials for ovarian clear-cell carcinoma with GlaxoSmithKline (NYSE:GSK), the compound is drawing increased institutional interest. Watch for news from upcoming oncology conferences, positive trial updates could be a catalyst for extended gains into after-hours.

Gamehaus Holdings (NASDAQ:GHSE) is riding a wave of renewed momentum as the esports and game-tech company garners attention for its integration of AI-driven training and performance tools for competitive gamers. With partnerships in development and whispers of expansion into collegiate and youth leagues, GHSE is back on trader radars as a speculative high-growth play. The stock has already made a strong intraday run, and if volume holds, it could test new highs in after-market trading.

AI infrastructure and analytics player Veritone (NASDAQ:VERI) is heating up again as investor attention swings back toward AI application platforms with real-world utility. Veritone’s government and media solutions, particularly in real-time transcription, video analysis, and compliance, are gaining traction amid rising demand for enterprise AI tools. Traders are eyeing this as a technical setup for a possible after-hours continuation.

Kindly MD (NASDAQ:KDLY) is gaining strength in power hour as traders react to its hybrid mental health and pain management clinic model, which blends telehealth, in-person care, and emerging AI-driven diagnostics. With a growing presence in underserved markets and an increasingly digital-first infrastructure, bulls are betting that Kindly MD could emerge as a scalable clinic-tech success story. Momentum is building on light resistance levels heading into the close.

CaliberCos (NASDAQ:CWD), a platform for alternative real estate investment, is showing signs of life late in the session as investors seek out under-the-radar inflation hedges and income-generating assets. With assets under management climbing and a growing footprint in opportunity zone development, CWD may benefit from renewed investor appetite for diversified, yield-driven plays, especially with Fed policy still in flux.

iSpecimen (NASDAQ:ISPC), a biospecimen procurement company powering AI-enhanced medical research, is seeing a subtle but steady uptick. With demand for curated, AI-compatible biological samples surging, and increased usage across oncology, neurology, and infectious disease research, ISPC is positioning itself as a quiet contributor to the AI-health crossover story. If volume accelerates, ISPC could surprise in after-hours.

Bon Natural Life (NASDAQ:BON) continues to impress after its recent rally, supported by expanding distribution channels in Asia and rising consumer demand for functional foods and plant-based health products. With improving margins and a strong growth narrative in nutraceuticals, BON could see renewed buying interest from both thematic and retail investors heading into earnings season.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by Microcap Advisory for providing ongoing LIXT market outreach and other services. Please review our Full Disclaimer https://www.247marketnews.com/disclaimer/. Please go to https://247marketnews.com/lixte-biotechnology/ for further LIXT and 247marketnews.com disclosure information.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (LIXT, GHSE, VERI, KDLY, CWD, ISPC)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.